2C
CDNA icon

272 Capital’s CareDx CDNA Stock Holding History

272 Capital’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-42,575
Closed -$451K – 69
2024
Q1 		$451K Buy
+42,575
New +$426K 0.18% 58

Other funds holding CDNA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

272 Capital's CDNA Position: Q2 2024 in Review

272 Capital sold out of CareDx (CDNA) in Q2 2024, closing a stake of 42,575 shares — an estimated $451K sold.

272 Capital first reported a position in CDNA in Q1 2024 and held it in 1 quarter. The position peaked at $451K in Q1 2024. 154 funds tracked by Wall St. Rank hold CDNA as of Q2 2024.

  • 272 Capital reported no remaining CareDx position as of Q2 2024 after selling out during the quarter.
  • 272 Capital sold 42,575 CareDx shares in Q2 2024, an estimated $451K.
  • 272 Capital first reported a position in CareDx in Q1 2024 and held it in 1 quarter.
  • 272 Capital's CareDx position peaked at $451K in Q1 2024.
  • 154 funds tracked by Wall St. Rank held CareDx as of Q2 2024.

Based on 272 Capital's 13F filing for Q2 2024, filed 14 Aug 2024.